PDL BioPharma
NASDAQ:PDLI
$6.49
$0.00
(0.00%)
Quote as of 3:22 PM EST on 02/09/12
PDL BioPharma to Present at the 14th Annual BIO CEO & Investor Conference
PDL BioPharma Announces Exchange of Its 2.875% Convertible Senior Notes due February 15, 2015
PDL BioPharma Announces Exchange of Its 2.875% Convertible Senior Notes due February 15, 2015
PDL BioPharma, Inc. (PDLI) Declares $0.15 Quarterly Dividend; 9.4% Yield
PDL BioPharma Announces 2012 Regular Quarterly Dividends
PDL BioPharma's CEO Presents at 30th Annual JP Morgan Healthcare Conference (Transcript)
PDL BioPharma sees Queen patents expiring 2013-14, royalties into 2016
PDL BioPharma affirms view of 2011 revenue $361M vs. consensus $369.95M
PDL BioPharma Announces Settlement and Final Results of its Exchange Offer
PDL BioPharma Announces Settlement and Final Results of its Exchange Offer
PDL BioPharma (PDLI) Gets 93.9% Response in Notes Exchange Offer
PDL BioPharma Announces Expiration and Preliminary Results of its Exchange Offer
PDL BioPharma Announces Expiration and Preliminary Results of its Exchange Offer
10 High Margin Healthcare Dividend Shares
Seth Klarman's 5 Newest Stock Picks
JP Morgan's biotechnology analyst holds a conference call
A Europe-Led Reversal (JAKK, PDLI, VPRT, WINN)
PDL BioPharma forecasts 5 pct 4Q revenue drop
Stocks to Watch: Vulcan, Zynga, Winn-Dixie (Update 2)
PDL BioPharma sees downbeat revenue
PDL BioPharma sees Q4 revenue approximately $72M vs. consensus $82.46M
PDL BioPharma (PDLI) Guides Q4, FY11 Revs Below Views
PDL BioPharma Provides Fourth Quarter 2011 Revenue Guidance of $72 Million
Biotech Royalties, Almost as Good as Cash
PDL BioPharma Completes Regular Quarterly Dividend Payment
PDL BioPharma Completes Regular Quarterly Dividend Payment
Seth Klarman's Stocks with Dividend Yield Over 4%
Drugmaker PDL BioPharma CFO Larson resigns
PDL BioPharma's (PDLI) CFO Christine Larson Announces Resignation
PDL BioPharma announces resignation of CFO Christine Larson
PDL BioPharma Announces Departure of Chief Financial Officer
Here's What 1 of the Best Investors Is Buying
Alexion Looks Fine With These 2 Metrics
Has PDL BioPharma Become the Perfect Stock?
PDL BioPharma Announces Adjusted Conversion Rates for Its Convertible Notes
PDL BioPharma About To Put More Money In Your Pocket
An Aggregated Top Yield Portfolio of Warren Buffett, Wilbur Ross, Seth Klarman and George Soros
Hedge Fund 13F Stock Picks: Profiting From Idea Season
